 | • レポートコード：MRC23Q38364 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のラピッドサイ鼻出血装置市場について調査・分析し、世界のラピッドサイ鼻出血装置市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（鼻タンポン、鼻カテーテル、その他）、用途別セグメント分析（前鼻出血、後鼻出血）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Teleflex Incorporated、Medtronic Plc、Smith and Nephew Plc、Stryker Corporation、Medline、King pharmaceuticals, Inc.、Entellus Medical, Inc.、Cirondrugs、Summit Medical, Inc.、GlaxoSmithKline Plcなどが含まれています。 世界のラピッドサイ鼻出血装置市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ラピッドサイ鼻出血装置市場規模を推定する際に考慮しました。本レポートは、ラピッドサイ鼻出血装置の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ラピッドサイ鼻出血装置に関するビジネス上の意思決定に役立てることを目的としています。 ・ラピッドサイ鼻出血装置市場の概要 - 製品の定義 - ラピッドサイ鼻出血装置のタイプ別セグメント - 世界のラピッドサイ鼻出血装置市場規模：タイプ別分析（鼻タンポン、鼻カテーテル、その他） - ラピッドサイ鼻出血装置の用途別セグメント - 世界のラピッドサイ鼻出血装置市場規模：用途別分析（前鼻出血、後鼻出血） - 世界のラピッドサイ鼻出血装置市場規模予測（2018年-2029年） - ラピッドサイ鼻出血装置の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - ラピッドサイ鼻出血装置市場の競争状況およびトレンド ・ラピッドサイ鼻出血装置の地域別市場規模 - 北米のラピッドサイ鼻出血装置市場規模（2018年-2029年） - アメリカのラピッドサイ鼻出血装置市場規模（2018年-2029年） - ヨーロッパのラピッドサイ鼻出血装置市場規模（2018年-2029年） - アジア太平洋のラピッドサイ鼻出血装置市場規模（2018年-2029年） - 中国のラピッドサイ鼻出血装置市場規模（2018年-2029年） - 日本のラピッドサイ鼻出血装置市場規模（2018年-2029年） - 韓国のラピッドサイ鼻出血装置市場規模（2018年-2029年） - インドのラピッドサイ鼻出血装置市場規模（2018年-2029年） - オーストラリアのラピッドサイ鼻出血装置市場規模（2018年-2029年） - 中南米のラピッドサイ鼻出血装置市場規模（2018年-2029年） - 中東・アフリカのラピッドサイ鼻出血装置市場規模（2018年-2029年） ・タイプ別セグメント：鼻タンポン、鼻カテーテル、その他 - 世界のラピッドサイ鼻出血装置のタイプ別販売量（2018年-2023年） - 世界のラピッドサイ鼻出血装置のタイプ別売上（2018年-2023年） - 世界のラピッドサイ鼻出血装置のタイプ別価格 ・用途別セグメント：前鼻出血、後鼻出血 - 世界のラピッドサイ鼻出血装置の用途別販売量（2018年-2023年） - 世界のラピッドサイ鼻出血装置の用途別売上（2018年-2023年） - 世界のラピッドサイ鼻出血装置の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Teleflex Incorporated、Medtronic Plc、Smith and Nephew Plc、Stryker Corporation、Medline、King pharmaceuticals, Inc.、Entellus Medical, Inc.、Cirondrugs、Summit Medical, Inc.、GlaxoSmithKline Plc ・産業チェーンと販売チャネルの分析 - ラピッドサイ鼻出血装置産業チェーン分析 - ラピッドサイ鼻出血装置の主要原材料 - ラピッドサイ鼻出血装置の販売チャネル - ラピッドサイ鼻出血装置のディストリビューター - ラピッドサイ鼻出血装置の主要顧客 ・ラピッドサイ鼻出血装置市場ダイナミクス - ラピッドサイ鼻出血装置の業界動向 - ラピッドサイ鼻出血装置市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Rapid Rhino Epistaxis Device market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Rapid Rhino Epistaxis Device is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Rapid Rhino Epistaxis Device is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Rapid Rhino Epistaxis Device include Teleflex Incorporated, Medtronic Plc, Smith and Nephew Plc, Stryker Corporation, Medline, King pharmaceuticals, Inc., Entellus Medical, Inc., Cirondrugs and Summit Medical, Inc., etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rapid Rhino Epistaxis Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Rhino Epistaxis Device.
The Rapid Rhino Epistaxis Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Rapid Rhino Epistaxis Device market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rapid Rhino Epistaxis Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Teleflex Incorporated
Medtronic Plc
Smith and Nephew Plc
Stryker Corporation
Medline
King pharmaceuticals, Inc.
Entellus Medical, Inc.
Cirondrugs
Summit Medical, Inc.
GlaxoSmithKline Plc
Segment by Type
Nasal Tampons
Nasal Catheters
Others
Segment by Application
Anterior epistaxis
Posterior epistaxis
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rapid Rhino Epistaxis Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rapid Rhino Epistaxis Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Rapid Rhino Epistaxis Device Market Overview
1.1 Product Overview and Scope of Rapid Rhino Epistaxis Device
1.2 Rapid Rhino Epistaxis Device Segment by Type
1.2.1 Global Rapid Rhino Epistaxis Device Market Value Comparison by Type (2023-2029)
1.2.2 Nasal Tampons
1.2.3 Nasal Catheters
1.2.4 Others
1.3 Rapid Rhino Epistaxis Device Segment by Application
1.3.1 Global Rapid Rhino Epistaxis Device Market Value by Application: (2023-2029)
1.3.2 Anterior epistaxis
1.3.3 Posterior epistaxis
1.4 Global Rapid Rhino Epistaxis Device Market Size Estimates and Forecasts
1.4.1 Global Rapid Rhino Epistaxis Device Revenue 2018-2029
1.4.2 Global Rapid Rhino Epistaxis Device Sales 2018-2029
1.4.3 Global Rapid Rhino Epistaxis Device Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Rapid Rhino Epistaxis Device Market Competition by Manufacturers
2.1 Global Rapid Rhino Epistaxis Device Sales Market Share by Manufacturers (2018-2023)
2.2 Global Rapid Rhino Epistaxis Device Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Rapid Rhino Epistaxis Device Average Price by Manufacturers (2018-2023)
2.4 Global Rapid Rhino Epistaxis Device Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Rapid Rhino Epistaxis Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rapid Rhino Epistaxis Device, Product Type & Application
2.7 Rapid Rhino Epistaxis Device Market Competitive Situation and Trends
2.7.1 Rapid Rhino Epistaxis Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rapid Rhino Epistaxis Device Players Market Share by Revenue
2.7.3 Global Rapid Rhino Epistaxis Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rapid Rhino Epistaxis Device Retrospective Market Scenario by Region
3.1 Global Rapid Rhino Epistaxis Device Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Rapid Rhino Epistaxis Device Global Rapid Rhino Epistaxis Device Sales by Region: 2018-2029
3.2.1 Global Rapid Rhino Epistaxis Device Sales by Region: 2018-2023
3.2.2 Global Rapid Rhino Epistaxis Device Sales by Region: 2024-2029
3.3 Global Rapid Rhino Epistaxis Device Global Rapid Rhino Epistaxis Device Revenue by Region: 2018-2029
3.3.1 Global Rapid Rhino Epistaxis Device Revenue by Region: 2018-2023
3.3.2 Global Rapid Rhino Epistaxis Device Revenue by Region: 2024-2029
3.4 North America Rapid Rhino Epistaxis Device Market Facts & Figures by Country
3.4.1 North America Rapid Rhino Epistaxis Device Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Rapid Rhino Epistaxis Device Sales by Country (2018-2029)
3.4.3 North America Rapid Rhino Epistaxis Device Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rapid Rhino Epistaxis Device Market Facts & Figures by Country
3.5.1 Europe Rapid Rhino Epistaxis Device Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Rapid Rhino Epistaxis Device Sales by Country (2018-2029)
3.5.3 Europe Rapid Rhino Epistaxis Device Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rapid Rhino Epistaxis Device Market Facts & Figures by Country
3.6.1 Asia Pacific Rapid Rhino Epistaxis Device Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Rapid Rhino Epistaxis Device Sales by Country (2018-2029)
3.6.3 Asia Pacific Rapid Rhino Epistaxis Device Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rapid Rhino Epistaxis Device Market Facts & Figures by Country
3.7.1 Latin America Rapid Rhino Epistaxis Device Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Rapid Rhino Epistaxis Device Sales by Country (2018-2029)
3.7.3 Latin America Rapid Rhino Epistaxis Device Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rapid Rhino Epistaxis Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Rapid Rhino Epistaxis Device Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Rapid Rhino Epistaxis Device Sales by Country (2018-2029)
3.8.3 Middle East and Africa Rapid Rhino Epistaxis Device Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rapid Rhino Epistaxis Device Sales by Type (2018-2029)
4.1.1 Global Rapid Rhino Epistaxis Device Sales by Type (2018-2023)
4.1.2 Global Rapid Rhino Epistaxis Device Sales by Type (2024-2029)
4.1.3 Global Rapid Rhino Epistaxis Device Sales Market Share by Type (2018-2029)
4.2 Global Rapid Rhino Epistaxis Device Revenue by Type (2018-2029)
4.2.1 Global Rapid Rhino Epistaxis Device Revenue by Type (2018-2023)
4.2.2 Global Rapid Rhino Epistaxis Device Revenue by Type (2024-2029)
4.2.3 Global Rapid Rhino Epistaxis Device Revenue Market Share by Type (2018-2029)
4.3 Global Rapid Rhino Epistaxis Device Price by Type (2018-2029)
5 Segment by Application
5.1 Global Rapid Rhino Epistaxis Device Sales by Application (2018-2029)
5.1.1 Global Rapid Rhino Epistaxis Device Sales by Application (2018-2023)
5.1.2 Global Rapid Rhino Epistaxis Device Sales by Application (2024-2029)
5.1.3 Global Rapid Rhino Epistaxis Device Sales Market Share by Application (2018-2029)
5.2 Global Rapid Rhino Epistaxis Device Revenue by Application (2018-2029)
5.2.1 Global Rapid Rhino Epistaxis Device Revenue by Application (2018-2023)
5.2.2 Global Rapid Rhino Epistaxis Device Revenue by Application (2024-2029)
5.2.3 Global Rapid Rhino Epistaxis Device Revenue Market Share by Application (2018-2029)
5.3 Global Rapid Rhino Epistaxis Device Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Teleflex Incorporated
6.1.1 Teleflex Incorporated Corporation Information
6.1.2 Teleflex Incorporated Description and Business Overview
6.1.3 Teleflex Incorporated Rapid Rhino Epistaxis Device Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Teleflex Incorporated Rapid Rhino Epistaxis Device Product Portfolio
6.1.5 Teleflex Incorporated Recent Developments/Updates
6.2 Medtronic Plc
6.2.1 Medtronic Plc Corporation Information
6.2.2 Medtronic Plc Description and Business Overview
6.2.3 Medtronic Plc Rapid Rhino Epistaxis Device Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Medtronic Plc Rapid Rhino Epistaxis Device Product Portfolio
6.2.5 Medtronic Plc Recent Developments/Updates
6.3 Smith and Nephew Plc
6.3.1 Smith and Nephew Plc Corporation Information
6.3.2 Smith and Nephew Plc Description and Business Overview
6.3.3 Smith and Nephew Plc Rapid Rhino Epistaxis Device Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Smith and Nephew Plc Rapid Rhino Epistaxis Device Product Portfolio
6.3.5 Smith and Nephew Plc Recent Developments/Updates
6.4 Stryker Corporation
6.4.1 Stryker Corporation Corporation Information
6.4.2 Stryker Corporation Description and Business Overview
6.4.3 Stryker Corporation Rapid Rhino Epistaxis Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Stryker Corporation Rapid Rhino Epistaxis Device Product Portfolio
6.4.5 Stryker Corporation Recent Developments/Updates
6.5 Medline
6.5.1 Medline Corporation Information
6.5.2 Medline Description and Business Overview
6.5.3 Medline Rapid Rhino Epistaxis Device Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Medline Rapid Rhino Epistaxis Device Product Portfolio
6.5.5 Medline Recent Developments/Updates
6.6 King pharmaceuticals, Inc.
6.6.1 King pharmaceuticals, Inc. Corporation Information
6.6.2 King pharmaceuticals, Inc. Description and Business Overview
6.6.3 King pharmaceuticals, Inc. Rapid Rhino Epistaxis Device Sales, Revenue and Gross Margin (2018-2023)
6.6.4 King pharmaceuticals, Inc. Rapid Rhino Epistaxis Device Product Portfolio
6.6.5 King pharmaceuticals, Inc. Recent Developments/Updates
6.7 Entellus Medical, Inc.
6.6.1 Entellus Medical, Inc. Corporation Information
6.6.2 Entellus Medical, Inc. Description and Business Overview
6.6.3 Entellus Medical, Inc. Rapid Rhino Epistaxis Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Entellus Medical, Inc. Rapid Rhino Epistaxis Device Product Portfolio
6.7.5 Entellus Medical, Inc. Recent Developments/Updates
6.8 Cirondrugs
6.8.1 Cirondrugs Corporation Information
6.8.2 Cirondrugs Description and Business Overview
6.8.3 Cirondrugs Rapid Rhino Epistaxis Device Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cirondrugs Rapid Rhino Epistaxis Device Product Portfolio
6.8.5 Cirondrugs Recent Developments/Updates
6.9 Summit Medical, Inc.
6.9.1 Summit Medical, Inc. Corporation Information
6.9.2 Summit Medical, Inc. Description and Business Overview
6.9.3 Summit Medical, Inc. Rapid Rhino Epistaxis Device Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Summit Medical, Inc. Rapid Rhino Epistaxis Device Product Portfolio
6.9.5 Summit Medical, Inc. Recent Developments/Updates
6.10 GlaxoSmithKline Plc
6.10.1 GlaxoSmithKline Plc Corporation Information
6.10.2 GlaxoSmithKline Plc Description and Business Overview
6.10.3 GlaxoSmithKline Plc Rapid Rhino Epistaxis Device Sales, Revenue and Gross Margin (2018-2023)
6.10.4 GlaxoSmithKline Plc Rapid Rhino Epistaxis Device Product Portfolio
6.10.5 GlaxoSmithKline Plc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rapid Rhino Epistaxis Device Industry Chain Analysis
7.2 Rapid Rhino Epistaxis Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rapid Rhino Epistaxis Device Production Mode & Process
7.4 Rapid Rhino Epistaxis Device Sales and Marketing
7.4.1 Rapid Rhino Epistaxis Device Sales Channels
7.4.2 Rapid Rhino Epistaxis Device Distributors
7.5 Rapid Rhino Epistaxis Device Customers
8 Rapid Rhino Epistaxis Device Market Dynamics
8.1 Rapid Rhino Epistaxis Device Industry Trends
8.2 Rapid Rhino Epistaxis Device Market Drivers
8.3 Rapid Rhino Epistaxis Device Market Challenges
8.4 Rapid Rhino Epistaxis Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer